GSK portfolio
GSK has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is LifeMine Therapeutics's $188M Series B+ round in August 2026, alongside Milky Way Investments, ARCH Venture Partners, Gates Frontier and 2 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with ARCH Venture Partners, RA Capital Management and Bezos Expeditions, most often ARCH Venture Partners (2 rounds).
What GSK invests in
- Health and bio · 2 · 100%
GSK recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $188M | Milky Way Investments (lead), ARCH Venture Partners, Gates Frontier +2 | ||
| Series A · $120M | UPMC Enterprises, Monograph Capital, NEA (lead) +4 | ||
| Series B+ · $175M | 3W Partners Capital, ARCH Venture Partners, Fidelity Management & Research Company (lead) +4 |
How GSK invests
GSK portfolio companies
LLifeMine Therapeutics$188MSeries B+ · Aug 2026
OOuro Medicines$120MSeries A · Jan 2025
| Company | Round with GSK | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $188M | $543M | Aug 6, 2026 Series B+ |
Health and bio |
Series A · $120M | $120M | Jan 10, 2025 Series A |
Most frequent co-investors
AARCH Venture Partners2 shared rounds · last Aug 6, 2026
RRA Capital Management1 shared round · last Aug 6, 2026
BBezos Expeditions1 shared round · last Aug 6, 2026
- GGates Frontier1 shared round · last Aug 6, 2026
MMilky Way Investments1 shared round · last Aug 6, 2026
NNEA1 shared round · last Jan 10, 2025
NNorwest Venture Partners1 shared round · last Jan 10, 2025
MMonograph Capital1 shared round · last Jan 10, 2025
TTPG1 shared round · last Jan 10, 2025
BBoyu Capital1 shared round · last Jan 10, 2025
UUPMC Enterprises1 shared round · last Jan 10, 2025
LLongRiver Investments1 shared round · last Jan 10, 2025
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 3 rounds on Recent Funding that name GSK. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists GSK, which is a subset of its real portfolio. API: /api/v1/investors/gsk (get a free API key). More: the most active VC firms and new venture capital funds.